(-)-Epigallocatechin-3-Gallate Ameliorates Atherosclerosis and Modulates Hepatic Lipid Metabolic Gene Expression in Apolipoprotein E Knockout Mice: Involvement of TTC39B
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00195
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 9, 2018
Authors
Publisher
Frontiers Media SA